Cargando…
Osteoarthritis-dependent changes in antinociceptive action of Na(v)1.7 and Na(v)1.8 sodium channel blockers: An in vivo electrophysiological study in the rat
Voltage-gated sodium channel blockers are not traditionally recommended for osteoarthritis (OA) pain therapy, but given the large peripheral drive that follows OA development there is a rationale for their use. Using a rat model of monosodium iodoacetate (MIA)-induced OA we used in vivo electrophysi...
Autores principales: | Rahman, W., Dickenson, A.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414363/ https://www.ncbi.nlm.nih.gov/pubmed/25818052 http://dx.doi.org/10.1016/j.neuroscience.2015.03.042 |
Ejemplares similares
-
Tramadol as a Voltage-Gated Sodium Channel Blocker of Peripheral Sodium Channels Na(v)1.7 and Na(v)1.5
por: Bok, Chan-Su, et al.
Publicado: (2023) -
Electrophysiological characterization of schizophrenia-associated variants in NaV1.2 sodium channel
por: Suslova, M., et al.
Publicado: (2022) -
Na(v)1.7 and Na(v)1.8: Role in the pathophysiology of pain
por: Hameed, Shaila
Publicado: (2019) -
The Changes in Expression of Na(V)1.7 and Na(V)1.8 and the Effects of the Inhalation of Their Blockers in Healthy and Ovalbumin-Sensitized Guinea Pig Airways
por: Kocmalova, Michaela, et al.
Publicado: (2021) -
Ciguatoxins Evoke Potent CGRP Release by Activation of Voltage-Gated Sodium Channel Subtypes Na(V)1.9, Na(V)1.7 and Na(V)1.1
por: Touska, Filip, et al.
Publicado: (2017)